Proceedings of the PSK Conference (대한약학회:학술대회논문집)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Clinical Effects of Gemcitabine/5-FU Theraphy vs. Epirubicin/Cisplatin/5-FU in Pancreatic Cancer

  • Huh, Sook (Graduate School of Clinical Pharmacy, Sookmyung Women′s University) ;
  • Lee, Suk-Hyang (Catholic University, Kangnam St. Mary′s Hospita) ;
  • Kang, Jin-Hyoung (Catholic University, Kangnam St. Mary′s Hospita) ;
  • Lee, Kyung-Sick (Catholic University, Kangnam St. Mary′s Hospita) ;
  • Lee, Myung-A (Catholic University, Kangnam St. Mary′s Hospital)
  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Gemcitabine demonstrated modest activity in locally advanced and metastatic pancreatic cancer with difficulty early diagnosis and poor prognisis. The purpose of this study was to evaluate the efficacy and toxicity of gemcitabine and 5-fluorouracil(GF) combination theraphy and epirubiciil, cisplatin. and 5-fluorouracil(ECF) combination theraphy for the patients with locally advanced or metaststic pancreatic cancer. Between January 1996 and December 2001, Patients with locally advanced or metastatic pancreatic cancer were selected and reviewed retrospectively at Kangnam St. Mary's Hospital. (omitted)

Keywords